Price Band
₹105 - ₹111
Lot Size
1200
Issue Size
₹59.98 Cr
GMP
N/A
Subscription
5.73x
Analyzing...
IPO Schedule
1
Open
5 Feb 2025
2
Close
7 Feb 2025
3
Allotment
-
4
Listing
12 Feb 2025
About Amwill Health Care
Amwill Healthcare is an SME focused on manufacturing and marketing pharmaceutical formulations across various therapeutic areas. They primarily operate in the domestic market, catering to diverse healthcare needs through a wide range of products.
Key Strengths
- High Return on Equity (ROE) of 73.06% indicates strong profitability and efficient use of shareholder capital.
- Reasonable Price-to-Earnings (P/E) ratio of 13.81 suggests potentially undervalued stock compared to industry peers, offering room for growth.
- Established presence in the pharmaceutical formulations market, providing a foundation for future expansion.
- Operates in a sector with consistent demand, as healthcare needs are relatively stable.
- Experience in manufacturing and marketing gives them end-to-end expertise.
Risk Factors
- •SME segment IPOs are inherently riskier due to smaller market capitalization and potential liquidity concerns.
- •Pharmaceutical industry is subject to regulatory changes and pricing pressures, which could impact profitability.
- •Competition from larger, more established pharmaceutical companies could limit market share growth.
Valuation Analysis
The IPO appears reasonably valued given the company's high ROE and moderate P/E ratio, however, investors should carefully consider the risks associated with SME IPOs before investing.
IPO Details
ExchangeBSE
SegmentSME
ISININE0U2L01017
Face Value₹10
Lot Size1200
Issue Size₹59.98 Cr
Key Metrics
ROE73.06%
ROCE94.16%
P/E Ratio13.81
Industry P/E20
EPS8.04
PAT Margin28.53%
Growth & Quality
ProfitableYes ✓
Subscription
Total1.04x
Documents
RHP not available
Key Dates
Open Date5 Feb 2025
Close Date7 Feb 2025
Listing12 Feb 2025